NRSN logo

NeuroSense Therapeutics (NRSN) Operating Profit

Annual Operating Profit

-$13.30 M
+$250.00 K+1.84%

December 1, 2023


Summary


Performance

NRSN Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNRSNprofitabilitymetrics:

Quarterly Operating Profit

-$2.11 M
+$923.00 K+30.46%

September 1, 2024


Summary


Performance

NRSN Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNRSNprofitabilitymetrics:

TTM Operating Profit

-$12.45 M
+$519.00 K+4.00%

September 1, 2024


Summary


Performance

NRSN TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNRSNprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

NRSN Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.8%+29.6%+6.5%
3 y3 years-360.6%+41.3%-32.7%
5 y5 years-977.1%+0.2%-489.6%

NRSN Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-138.1%+1.8%-28.1%+51.2%-122.8%+8.2%
5 y5-year-977.1%+1.8%-139.4%+51.2%-489.6%+8.2%
alltimeall time-977.1%+1.8%-139.4%+51.2%-489.6%+8.2%

NeuroSense Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.11 M(-30.5%)
-$12.45 M(-4.0%)
Jun 2024
-
-$3.03 M(+1.2%)
-$12.96 M(-2.6%)
Mar 2024
-
-$2.99 M(-30.6%)
-$13.30 M(+0.0%)
Dec 2023
-$13.30 M(-1.8%)
-$4.32 M(+64.3%)
-$13.30 M(+7.6%)
Sep 2023
-
-$2.63 M(-22.1%)
-$12.37 M(-5.3%)
Jun 2023
-
-$3.37 M(+12.7%)
-$13.06 M(-1.7%)
Mar 2023
-
-$2.99 M(-11.5%)
-$13.28 M(-2.0%)
Dec 2022
-$13.55 M
-$3.38 M(+1.8%)
-$13.55 M(+14.7%)
Sep 2022
-
-$3.32 M(-7.5%)
-$11.82 M(+26.0%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$3.59 M(+10.0%)
-$9.38 M(+39.2%)
Mar 2022
-
-$3.26 M(+98.4%)
-$6.74 M(+20.6%)
Dec 2021
-$5.59 M(+93.5%)
-
-
Dec 2021
-
-$1.65 M(+86.9%)
-$5.59 M(+41.7%)
Sep 2021
-
-$880.00 K(-7.5%)
-$3.94 M(+28.7%)
Jun 2021
-
-$951.00 K(-55.0%)
-$3.06 M(+45.0%)
Mar 2021
-
-$2.11 M
-$2.11 M
Dec 2020
-$2.89 M(+133.8%)
-
-
Dec 2019
-$1.24 M
-
-

FAQ

  • What is NeuroSense Therapeutics annual operating income?
  • What is the all time high annual operating profit for NeuroSense Therapeutics?
  • What is NeuroSense Therapeutics annual operating profit year-on-year change?
  • What is NeuroSense Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for NeuroSense Therapeutics?
  • What is NeuroSense Therapeutics quarterly operating profit year-on-year change?
  • What is NeuroSense Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for NeuroSense Therapeutics?
  • What is NeuroSense Therapeutics TTM operating profit year-on-year change?

What is NeuroSense Therapeutics annual operating income?

The current annual operating profit of NRSN is -$13.30 M

What is the all time high annual operating profit for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high annual operating income is -$1.24 M

What is NeuroSense Therapeutics annual operating profit year-on-year change?

Over the past year, NRSN annual operating income has changed by +$250.00 K (+1.84%)

What is NeuroSense Therapeutics quarterly operating income?

The current quarterly operating profit of NRSN is -$2.11 M

What is the all time high quarterly operating profit for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high quarterly operating income is -$880.00 K

What is NeuroSense Therapeutics quarterly operating profit year-on-year change?

Over the past year, NRSN quarterly operating income has changed by +$887.00 K (+29.63%)

What is NeuroSense Therapeutics TTM operating income?

The current TTM operating profit of NRSN is -$12.45 M

What is the all time high TTM operating profit for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high TTM operating income is -$2.11 M

What is NeuroSense Therapeutics TTM operating profit year-on-year change?

Over the past year, NRSN TTM operating income has changed by +$859.00 K (+6.46%)